The Dutch biotech Synaffix has long been one of the top partners for biopharma companies working in antibody-drug conjugates. Now the company is spinning out … ...
Kivu is joining in. Chief Operating Officer Mohit Trikha said that ADC tolerability has limited how large of a dose developers can safely use, or cause people to stop treatment. Unstable linker ...
India’s Prime Minister Narendra Modi shakes hands with Chinese President Xi Jinping ahead of a meeting on the sidelines of the BRICS summit at Kazan, Russia, Oct. 23, 2024. Credit: X/Narendra ...
“The preliminary results from the ongoing Phase 1 trial of ZL-1310 suggest that this next-generation ADC therapy has the potential to deliver anti-tumor responses in the majority of patients ...
With elements of Battlefield and Escape From Tarkov baked into the multiplayer modes, it’s a tactical shooter enjoying immense success on Steam already. There’s even a single-player campaign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback